Follow
Tetsuji Itoh
Tetsuji Itoh
Verified email at merck.com
Title
Cited by
Cited by
Year
Asymmetric synthesis of telcagepant, a CGRP receptor antagonist for the treatment of migraine
F Xu, M Zacuto, N Yoshikawa, R Desmond, S Hoerrner, T Itoh, M Journet, ...
The Journal of Organic Chemistry 75 (22), 7829-7841, 2010
1092010
Total synthesis of (−)-CP-263,114 (Phomoidride B)
N Waizumi, T Itoh, T Fukuyama
Journal of the American Chemical Society 122 (32), 7825-7826, 2000
1082000
Engineered ribosyl-1-kinase enables concise synthesis of molnupiravir, an antiviral for COVID-19
JA McIntosh, T Benkovics, SM Silverman, MA Huffman, J Kong, ...
ACS Central Science 7 (12), 1980-1985, 2021
1002021
Synthetic studies on CP-225,917 and CP-263,114
N Waizumi, T Itoh, T Fukuyama
Tetrahedron letters 39 (33), 6015-6018, 1998
751998
Highly efficient synthesis of HIV NNRTI doravirine
DR Gauthier Jr, BD Sherry, Y Cao, M Journet, G Humphrey, T Itoh, ...
Organic letters 17 (6), 1353-1356, 2015
432015
A new synthetic route to phomoidride B and its derivatives
Y Hayashi, T Itoh, T Fukuyama
Organic Letters 5 (13), 2235-2238, 2003
342003
Synthetic approach to tetrodotoxin
T Itoh, M Watanabe, T Fukuyama
Synlett 2002 (08), 1323-1325, 2002
312002
Electrochemical recycling of adenosine triphosphate in biocatalytic reaction cascades
S Ruccolo, G Brito, M Christensen, T Itoh, K Mattern, K Stone, ...
Journal of the American Chemical Society 144 (49), 22582-22588, 2022
202022
New semi-automated computer-based system for assessing the purge of mutagenic impurities
MJ Burns, MA Ott, A Teasdale, SA Stalford, V Antonucci, JC Baumann, ...
Organic process research & development 23 (11), 2470-2481, 2019
192019
Utilizing biocatalysis and a sulfolane-mediated reductive acetal opening to access nemtabrutinib from cyrene
N Kuhl, BWH Turnbull, Y Ji, RT Larson, M Shevlin, CK Prier, CK Chung, ...
Green Chemistry 25 (2), 606-613, 2023
132023
Development of a Practical Manufacturing Process to Relebactam via Thorough Understanding of the Origin and Control of Oligomeric Impurities
J Kim, T Itoh, F Xu, ZEX Dance, JH Waldman, DJ Wallace, F Wu, ...
Organic Process Research & Development 25 (10), 2249-2259, 2021
42021
Process for making reverse transcriptase inhibitors
Y Cao, DR Gauthier Jr, GR Humphrey, T Itoh, M Journet, G Qian, ...
US Patent 9,598,397, 2017
32017
Synthesis of Fused Oxepane HIV Integrase Inhibitor MK-1376
PE Maligres, ZJ Song, NA Strotman, J Yin, T Pei, HR Strotman, T Itoh, ...
Synthesis 52 (22), 3378-3388, 2020
22020
Process for making reverse transcriptase inhibitors
T Itoh, I Jeon, I Mangion, G Qian, BD Sherry, DR Gauthier, Y Cao
US Patent 9,663,490, 2017
22017
Directed Evolution to Reverse Epoxide Hydrolase Enantioselectivity for meso‐3,4‐Epoxytetrahydrofuran
K Hiraga, T Itoh, D Verma, W Wang, C Huang, M Ardolino, YL Zhong, ...
ChemCatChem 15 (12), e202300238, 2023
12023
Process for making tetracyclic heterocycle compounds
H Li, J Yin, KM Belyk, KR Campos, Q Chen, AM Hyde, T Itoh, A Klapars, ...
US Patent 10,202,401, 2019
12019
Synthesis of antiviral nucleosides
T Benkovics, PS Fier, A Fryszkowska, MA Huffman, T Itoh, J Kong, ...
US Patent App. 18/256,058, 2024
2024
PROCESS FOR THE PREPARATION OF INTERMEDIATES USEFUL FOR MAKING (2S, 5R)-7-OXO-N-PIPERIDIN-4-YL-6-(SULFOXY)-l, 6-DIAZABICYCLO [3.2. 1] OCTANE-2-CARBOXAMIDE
JYL Chung, T Itoh, J Kim, JH Waldman, DJ Wallace, A Wood, F Xu, ...
US Patent App. 17/604,525, 2022
2022
Process for preparing substituted tetracyclic heterocycle compounds
J Yin, T Itoh, J Yin, B Xiang, KR Campos, A Kalinin, Z Liu, MD Christensen, ...
US Patent 10,457,690, 2019
2019
Process for making tetracyclic heterocycle compounds
H Li, J Yin, KM Belyk, KR Campos, Q Chen, AM Hyde, T Itoh, A Klapars, ...
US Patent App. 15/325,392, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–20